Fulcrum Therapeutics Inc
NASDAQ:FULC

Watchlist Manager
Fulcrum Therapeutics Inc Logo
Fulcrum Therapeutics Inc
NASDAQ:FULC
Watchlist
Price: 3.32 USD -6.74% Market Closed
Market Cap: 207.2m USD
Have any thoughts about
Fulcrum Therapeutics Inc?
Write Note

Fulcrum Therapeutics Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fulcrum Therapeutics Inc
Net Change in Cash Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Fulcrum Therapeutics Inc
NASDAQ:FULC
Net Change in Cash
$52.9m
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Change in Cash
$252m
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Net Change in Cash
$325m
CAGR 3-Years
N/A
CAGR 5-Years
-58%
CAGR 10-Years
-20%
Pfizer Inc
NYSE:PFE
Net Change in Cash
-$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Change in Cash
$6B
CAGR 3-Years
31%
CAGR 5-Years
169%
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Net Change in Cash
$988.2m
CAGR 3-Years
72%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Fulcrum Therapeutics Inc's Net Change in Cash?
Net Change in Cash
52.9m USD

Based on the financial report for Jun 30, 2024, Fulcrum Therapeutics Inc's Net Change in Cash amounts to 52.9m USD.

What is Fulcrum Therapeutics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
5%

Back to Top